Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
F. Fanfulla, R. Trentin, A. Carlucci, M. Mancini, M. Piran, S. Nava (Pavia, Italy). Physiological and anthropometric differences among OSA patients requiring CPAP or autoBiPAP Mseries® treatment. Eur Respir J 2010; 36: Suppl. 54, 931

Member's Comments

No comment yet.

Related content which might interest you: Pressure changes after CPAP titration in OSAS patients with poor clinical response to mathematic adjustment Source: Annual Congress 2007 - Nursing interventions in the prevention and management of respiratory disease Year: 2007 Effect of auto-CPAP therapy on parameters of rhinomanometry in patients with COPD combined with OSAHS Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Anthropometric and polysomnographic indices that influence optimal continuous positive airway pressure (CPAP) in sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007 Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Long-term nCPAP compliance in patients with OSAS with initial in-hospital adjustment of nCPAP Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 Predicting optimum continuous positive airway pressure (CPAP) from anthropometric and polysomnographic indices Source: Eur Respir J 2005; 26: Suppl. 49, 113s Year: 2005 The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Outcomes of OSA and indications for different therapies Source: Eur Respir Mon 2010; 50: 225-243 Year: 2010 Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 CPAP and measures of cardiovascular risks in patients with OSAS Source: Eur Respir J 2009; 33: 1520 Year: 2009 Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Weight and metabolic effects of CPAP in OSA patients with obesity Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Evaluation of polysomnographic data in OSAS patients with cardiac diseases Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea Year: 2009 Compliance to ventilatory treatment in a cohort of patients on home CPAP or NIV: analysis by diagnosis, treatment type, and comorbidities Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019